Sclera Care Topical Anesthetic Gel
NDC Package 73698-281-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Sclera Care Topical Anesthetic Gel (lidocaine hydrochloride) gel is • Adults and children two-years of age or older: Apply to affected area not more than three to four times daily. This formulation utilizes a gel delivery system. Marketed by Scleracare, Llc, this product is identified by NDC 73698-281 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
73698-281-01
Package Description
118 mL in 1 BOTTLE
Product Code
73698-281
11-Digit Billing Format
73698028101
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sclera Care Topical Anesthetic Gel
Non-Proprietary Name
Lidocaine Hydrochloride
Substance Name
Lidocaine Hydrochloride
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
LIDOCAINE HYDROCHLORIDE 30 mg/mL
Pharmacologic Class
Usage Information
• Adults and children two-years of age or older: Apply to affected area not more than three to four times daily. • Children under two-years of age: Consult a physician.

Regulatory & Marketing

Labeler Name
Scleracare, Llc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-21-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (73698-281). Click a package code to view its specific billing and regulatory data.

73698-281-00
5 mL in 1 PACKET

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73698-281-01 identifies a specific commercial package of 118 ml in 1 bottle of Sclera Care Topical Anesthetic Gel, a human over the counter drug labeled by Scleracare, Llc. This gel is formulated for topical use and contains lidocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Scleracare, Llc on March 21, 2022. The current certification is valid through December 31, 2026.

How is this Scleracare, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73698028101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73698-281-01
11-Digit CMS (5-4-2)
73698-0281-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.